Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

A reliable method was developed to measure gemcitabine and olaparib in pancreatic tissue, aiding pancreatic cancer treatment.

Image analysis can effectively identify changes in scalps affected by chemotherapy-induced hair loss.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The new therapy effectively targets brain tumors while minimizing damage to healthy tissue.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

FDG PET/CT can improve cancer treatment plans in dogs.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Some supplements may help reduce side effects of cancer treatments in pets.

Topical Minoxidil effectively and safely regrows hair in cancer patients.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Horticultural therapy helped cancer patients feel hopeful and positive about their disease experience.

Promising cancer treatments were found, but the manufacturer closed.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.